Addressing Barriers to Clinical Implementation of Pharmacogenomics
Pharmacogenomics offers one of the best use cases for widespread clinical implementation of genomic medicine, as variants tend to have moderate allele frequencies, many of the affected medications are relatively common, and the magnitude of effect tends to be clinically meaningful. Using pharmacogen...
Main Author: | Wiley, Laura Katherine |
---|---|
Other Authors: | Joshua C. Denny |
Format: | Others |
Language: | en |
Published: |
VANDERBILT
2016
|
Subjects: | |
Online Access: | http://etd.library.vanderbilt.edu/available/etd-03282016-113802/ |
Similar Items
-
Pharmacogenomics and Personalized Medicine
by: Erika Cecchin, et al.
Published: (2020-06-01) -
The fallacy of racial pharmacogenomics
by: S.D.J. Pena
Published: (2011-04-01) -
The fallacy of racial pharmacogenomics
by: S.D.J. Pena
Published: (2011-04-01) -
Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
by: Masahiro Hiratsuka, et al.
Published: (2021-08-01) -
Personalized Medicine: Studies of Pharmacogenomics in Yeast and Cancer
by: Chen, Bo-Juen
Published: (2013)